OSHA delays enforcement of limitations on post-accident drug testing

by McAfee & Taft

In previous articles, we discussed the Occupational Safety and Health Administration’s (OSHA) new rule regarding the reporting of workplace injuries and illnesses.

One part of the rule requires employers to electronically submit injury and illness data. This portion of the rule is set to go into effect on January 1, 2017.

Rule’s anti-retaliation provisions delayed

Another portion of the rule adds language to prohibit employers from retaliating against workers who have reported work-related injuries and illnesses. This anti-retaliation portion of the rule was initially set to go into effect on August 10, 2016. In light of a lawsuit filed in the Northern District of Texas, OSHA delayed enforcement until November 1, 2016. Recently, OSHA again delayed enforcement of the anti-retaliation provisions until December 1, 2016.

The anti-retaliation provisions of the final rule state that (1) an employer’s procedure for reporting work-related injuries and illnesses must be reasonable and must not deter or discourage reasonable employees from reporting work-related injuries and illnesses; (2) employers must inform employees of their right to report work-related injuries and illnesses free from retaliation; and (3) employers must not discharge or discriminate against an employee for reporting a work-related injury or illness.

Rule’s effect on post-accident drug testing and safety incentive programs

One big issue for employers is what effect these anti-retaliation provisions have on routine post-accident drug testing programs and incident-based safety incentive programs. At one point, OSHA seemed to suggest that these programs would be considered retaliatory and therefore violate the new rule.

For example, in commentary to the new rule, OSHA stated that drug testing policies should limit post-incident testing to situations in which employee drug use is likely to have contributed to the incident, and for which the drug test can accurately identify impairment caused by drug use. Yet, as there are no generally recognized drug tests that can show actual impairment available to employers at this time, the ability of an employer to meet OSHA’s proposed standard is impossible.

OSHA memo clarifies new rule

On October 19, 2016, OSHA issued a memorandum explaining its position on the new rule in more detail. Specifically with respect to how the new anti-retaliation provisions apply to post-accident drug testing policies and employee incentive programs, OSHA clarified that in order for it to find an employer in violation of the new rule, OSHA must demonstrate the following elements:

  1. The employee reported a work-related injury or illness;
  2. The employer took adverse action against the employee (that is, action that would deter a reasonable employee from accurately reporting a work-related injury or illness); and
  3. The employer took the adverse action because the employee reported a work-related injury or illness.

Thus, regardless of whether an adverse action is taken pursuant to a disciplinary policy, post-accident drug testing policy, or employee incentive program, OSHA’s ultimate burden is to prove that the employer took the adverse action because the employee reported a work-related injury or illness, not for a legitimate business reason. OSHA reminds employers that its analysis will be a fact-specific inquiry made on a case-by-case basis.

In this memorandum, OSHA also states that the new rule does not prohibit employers from drug testing employees who report work-related injuries or illnesses so long as they have an objectively reasonable basis for testing, and the rule does not apply to drug testing employees for reasons other than injury reporting. The new rule only prohibits drug testing employees who report work-related injuries and illnesses when the employer has no objectively reasonable basis for doing so. In cases of drug testing, in order to find a violation, OSHA will have to find the three elements of retaliation stated above: a protected report of an injury or illness; adverse action; and causation.

When evaluating whether an employer had a reasonable basis for drug testing an employee who reported a work-related injury or illness, OSHA will focus on whether the employer had a reasonable basis for believing that drug use by the reporting employee could have contributed to the injury or illness.

Importantly, OSHA clarifies that it will only consider whether the drug test is capable of measuring impairment at the time the injury or illness occurred where such a test is available. Therefore, at this time, OSHA will consider this factor for tests that measure alcohol use, but not for tests that measure the use of any other drugs.

The general principle OSHA aims to establish is that drug testing may not be used by the employer as a form of discipline against employees who report an injury or illness, but may be used as a tool to evaluate the root causes of workplace injuries and illness in appropriate circumstances. Moreover, OSHA makes clear that drug testing conducted pursuant to state workers’ compensation laws or other state or federal law is not a violation of its new rule.

Takeaway for employers

The OSHA memorandum boils down to this: Not all post-accident drug testing will be considered retaliatory or unlawful. OSHA must make a fact-specific inquiry to determine if an employer has violated the new rule. If an employer has an objectively reasonable basis for testing and applies its post-accident testing policy consistently, it could survive the scrutiny of the new rule.

We will keep our eyes on the Northern District of Texas lawsuit and advise of any further developments. However, do not wait until December 1, 2016, to determine whether your policies, including post-accident drug testing, comply with OSHA’s final rule.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© McAfee & Taft | Attorney Advertising

Written by:

McAfee & Taft

McAfee & Taft on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.